Avanos Medical, Inc. (AVNS) Comparison with companies in other sectors?

Avanos Medical, Inc. has a share price of 46.24M. You can analyze Avanos Medical, Inc. (AVNS) competitors across different market sectors through stock heatmaps.

What are AVNS's NET and operating margins?

Avanos Medical, Inc. (AVNS) operating margin is around -0.55, and net profit margin is approximately -0.56 as of the latest reports.

In what way does AVNS's earnings per share (EPS) trend reflect its financial momentum?

Avanos Medical, Inc. (AVNS) EPS is -8.27 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Avanos Medical, Inc. is -1.45, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Avanos Medical, Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Avanos Medical, Inc. like P/E which is -1.44, P/B which is 0.66, and PEG which is -0.77. Compare them with sector averages to evaluate if the stock is priced fairly.

Avanos Medical, Inc.

AVNS•NYSE

Healthcare

Medical - Devices

$12.01

$0.13(1.09%)

Fundamental Analysis of Avanos Medical, Inc. (AVNS)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$-8.27

P/E Ratio

-1.45

ROE

-0.37%

Net Margin

-0.56%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$555.39M

Shares OutstandingTotal number of shares issued

$46.24M

Book Value/ShareNet worth per share

$18.21

Revenue/ShareAnnual revenue per share

$14.95

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-8.27

Net MarginNet income as percentage of revenue

-55.80%

Operating MarginOperating income as percentage of revenue

-55.15%

ROEReturn on shareholders' equity

-37.34%

ROAReturn on total assets

-34.72%

ROCEReturn on capital employed

-39.16%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$2.47

Cash/ShareCash and equivalents per share

$2.10

FCF YieldFree cash flow as percentage of market cap

20.49%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for AVNSFinancial Ratios Analysis details for AVNS are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for AVNSSector Benchmarking details for AVNS are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Avanos Medical, Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Avanos Medical, Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Avanos Medical, Inc.'s unique business strengths and challenges.

Key Financial Metrics for Avanos Medical, Inc.

For Avanos Medical, Inc., essential financial indicators include EPS -8.27, PE -1.45, and ROE -0.37. These key ratios reveal insights into Avanos Medical, Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare Avanos Medical, Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Avanos Medical, Inc.

Metrics like Net Margin -55.80% and ROA -34.72% shed light on how well Avanos Medical, Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Avanos Medical, Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of Avanos Medical, Inc.

Using ratios such as P/B Ratio 0.66 and PEG Ratio -0.77, investors can assess whether Avanos Medical, Inc. is appropriately valued based on its financials and growth potential. These figures, combined with Avanos Medical, Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Avanos Medical, Inc.

Financial health indicators, such as Debt/Equity Ratio 0.17 and Cash Flow $2.47, provide a snapshot of Avanos Medical, Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Avanos Medical, Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Avanos Medical, Inc.

Investing in Avanos Medical, Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Avanos Medical, Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;